# Executive Summary: Enterprise C Bioprocessing Facility

> **Author:** Site Director
> **Scope:** Enterprise C - rBMN-42 Production
> **Industry:** Bioprocessing / Pharmaceutical Manufacturing
> **January 2026**

---

## Background

Enterprise C operates a single-train bioprocessing facility producing rBMN-42, a recombinant biologic currently in commercial manufacturing. Our process consists of four integrated units: a 500L media preparation system (SUM500), a 250L bioreactor for upstream cell culture (UNIT-250), a chromatography skid for downstream purification (CHR01), and tangential flow filtration for final concentration (TFF300).

With 188 process tags generating continuous data across batch operations, we faced a fundamental challenge: how do we transform raw process data into the contextualized batch records required for GMP compliance?

## The Regulatory Burden We Faced

Before UNS implementation, our batch record documentation was fragmented across multiple systems. Operators maintained paper logbooks for phase transitions while historians captured raw sensor data. When investigating a dissolved oxygen excursion during fermentation, our quality team spent days manually correlating timestamps between systems, attempting to prove that our TIC101 temperature control remained within specification during the event.

For a facility where a single batch failure represents a potential loss exceeding one million dollars, this documentary burden was unsustainable.

## What UNS Delivers for Compliance

The Sparkplug B implementation now publishes every tag with full batch context embedded in the namespace structure. When our UNIT-250 bioreactor reports dissolved oxygen via AIC101_DO_PV, that value arrives with the batch identifier (rBMN42-2026-0042), the current phase, and the equipment state:

```
spBv1.0/Enterprise C/NDATA/sub/AIC101_DO_PV     -- The measurement
spBv1.0/Enterprise C/NDATA/sub/BATCH_ID         -- Which batch
spBv1.0/Enterprise C/NDATA/sub/PHASE            -- Which phase
spBv1.0/Enterprise C/NDATA/sub/STATE            -- Equipment state
```

This is not merely operational convenience. This is 21 CFR Part 11 data integrity achieved at the source.

Our critical process parameters for cell culture—dissolved oxygen, pH, and temperature—are now inherently correlated with batch phase. When regulators ask during inspection how we demonstrated process control during the growth phase of a specific batch, we provide a unified dataset rather than a reconstructed narrative assembled from disparate sources.

## The ALCOA+ Imperative

Data integrity in pharmaceutical manufacturing follows ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available. The UNS architecture directly addresses each requirement:

| Principle | How UNS Delivers |
|-----------|------------------|
| **Attributable** | Operator acknowledgments (ACK_INOCULATION, ACK_HARVEST) tied to batch context |
| **Contemporaneous** | Real-time publication at the moment of measurement |
| **Original** | Sparkplug B birth/death certificates establish data provenance |
| **Complete** | 188 tags covering all critical process parameters |
| **Consistent** | ISA-5.1 tag naming (TIC101_PV, AIC101_DO_SP) across all units |

## Operational and Financial Impact

The operator acknowledgment requirements embedded in our ISA-88 control philosophy now flow through UNS alongside process data. Phase transitions, recipe parameter confirmations, and deviation acknowledgments become part of a continuous electronic batch record. Our operators spend less time on documentation and more time on process oversight.

For deviation investigation, the value is substantial. Last month, we identified a transmembrane pressure trend in TFF300 that would have resulted in batch failure. Because historical data was contextualized by batch and phase, we traced the issue to a specific recipe step within hours rather than days.

That single investigation improvement justified months of implementation effort.

## Process Analytical Technology Foundation

The path to continuous process verification requires real-time correlation of critical quality attributes with process parameters. Our UNS implementation provides exactly this:

- Dissolved oxygen cascade control (AIC101_DO_PV/SP) correlated with gas flow rates (FIC101_AIR, FIC102_O2)
- pH control (AIC101_PH_PV) correlated with base addition (PMP102 totalized volume)
- Chromatography inline analytics (UV, pH, conductivity) correlated with gradient progression
- TFF flux decay correlated with concentration factor

When we file our next BLA supplement, the process characterization data will come from a single, contextualized source.

## Forward View

As we prepare supplemental filings with FDA, our Process Analytical Technology strategy now rests on a foundation of contextualized, traceable data. The path toward continuous process verification requires exactly this capability: real-time correlation of critical quality attributes with process parameters, organized by batch and phase, accessible for trend analysis across our production history.

The UNS implementation transforms Enterprise C from a facility that generates data into one that generates knowledge.

For a regulated manufacturer, that distinction determines both compliance posture and competitive position.

---

**Site Director**
*Enterprise C Bioprocessing Facility*
